<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M852</article-id>
      <article-id pub-id-type="publisher-id">molbank-2015-M852</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>N</italic>-benzyl-(3<italic>E</italic>,5<italic>E</italic>)-3,5-bis(2-hydroxybenzylidene)-4-piperidone</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Eryanti</surname>
            <given-names>Yum</given-names>
          </name>
          <xref rid="af1-molbank-2015-M852" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herlina</surname>
            <given-names>Tati</given-names>
          </name>
          <xref rid="af2-molbank-2015-M852" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zamri</surname>
            <given-names>Adel</given-names>
          </name>
          <xref rid="af1-molbank-2015-M852" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shiono</surname>
            <given-names>Yoshihito</given-names>
          </name>
          <xref rid="af3-molbank-2015-M852" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Awang</surname>
            <given-names>Khalijah</given-names>
          </name>
          <xref rid="af4-molbank-2015-M852" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Halim</surname>
            <given-names>Siti Nadiah Abdul</given-names>
          </name>
          <xref rid="af4-molbank-2015-M852" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Supratman</surname>
            <given-names>Unang</given-names>
          </name>
          <xref rid="af2-molbank-2015-M852" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2015-M852" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2015-M852"><label>1</label>Laboratory of Organic Synthesis, Department of Chemistry, Faculty of Mathematics and Natural Sciences, Riau University, Pekanbaru, 26293, Indonesia; E-Mails: <email>ym_eryanti@yahoo.com</email> (Y.E.); <email>adelzamri@yahoo.com</email> (A.Z.)</aff>
      <aff id="af2-molbank-2015-M852"><label>2</label>Department of Chemistry, Faculty of Mathematics and Narural Sciences, Padjadjaran University, Jalan Raya Bandung-Sumedang Km 21, Jatinangor 45363, Sumedang, Indonesia; E-Mail: <email>herlinatati13@yahoo.com</email></aff>
      <aff id="af3-molbank-2015-M852"><label>3</label>Department of Bioresource Engineering, Faculty of Agriculture, Yamagata University, 1-23 Wakabamachi, Tsuruoka 997-8555, Japan; E-Mail: <email>yshiono@tds1.tr.yamagata-u.ac.jp</email></aff>
      <aff id="af4-molbank-2015-M852"><label>4</label>Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur 59100, Malaysia; E-Mails: <email>khalijah@um.edu.my</email> (K.A.); <email>nadiahhalim@um.edu.my</email> (S.N.A.H.)</aff>
      <author-notes>
        <corresp id="c1-molbank-2015-M852"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>u_supratman@unpad.ac.id</email>; Tel./Fax: +62-22-7794391.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>02</day>
        <month>04</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2015</year>
      </pub-date>
      <volume>2015</volume>
      <issue>2</issue>
      <elocation-id>M852</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>02</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>03</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A novel <italic>N</italic>-benzyl-(3<italic>E</italic>,5<italic>E</italic>)-3,5-bis(2-hydroxybenzylidene)-4-piperidone (<bold>3</bold>), was synthesized in good yield by a condensation reaction of 2-hydroxybenzaldehyde (<bold>1</bold>) and <italic>N-</italic>benzyl-4-piperidone (<bold>2</bold>) under microwave irradiation in the presence of 10% NaOH solution. The chemical structure was assigned on the basis of UV-visible, IR, <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and mass spectral data.</p>
      </abstract>
      <kwd-group>
        <kwd>curcumin</kwd>
        <kwd><italic>N</italic>-benzyl-4-piperidone</kwd>
        <kwd><italic>N</italic>-benzyl-(3<italic>E</italic>,5<italic>E</italic>)-3,5-bis(2-hydroxybenzylidene)-4-piperidone</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Curcumin (diferuloylmethane) is an orange-yellow and dietary polyphenolic phytochemical in turmeric (<italic>Curcuma longa</italic>). In recent decades, curcumin has been shown to exhibit antioxidant [<xref ref-type="bibr" rid="B1-molbank-2015-M852">1</xref>], anti-inflammatory [<xref ref-type="bibr" rid="B2-molbank-2015-M852">2</xref>], antiviral [<xref ref-type="bibr" rid="B3-molbank-2015-M852">3</xref>], antibacterial [<xref ref-type="bibr" rid="B4-molbank-2015-M852">4</xref>] effects, and thus has potential use against various malignant cancers, diabetes, allergies, arthritis and other chronic illnesses [<xref ref-type="bibr" rid="B5-molbank-2015-M852">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2015-M852">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2015-M852">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2015-M852">8</xref>]. For the purpose of finding novel derivatives with increased systemic bioavailability and enhanced pharmacological activity [<xref ref-type="bibr" rid="B9-molbank-2015-M852">9</xref>], chemical modifications as well as synthesis of curcumin analogues have been attempted by many research groups to find a better treatment for various diseases [<xref ref-type="bibr" rid="B9-molbank-2015-M852">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2015-M852">10</xref>]. Analogous compounds to (<italic>E</italic>)-3,5-bis(benzylidene)-4-piperidones presented noteworthy cytotoxic activity against leukimia cell lines and colon cancer among others [<xref ref-type="bibr" rid="B11-molbank-2015-M852">11</xref>]. Different substituents with opposing electronic properties in the benzene rings were designed to investigate and discuss the structure&#x2013;activity relationship [<xref ref-type="bibr" rid="B12-molbank-2015-M852">12</xref>]. During the course of our continuing search for novel curcumin analogues, we synthesized and characterized 3,4-bis(2-hydroxybenzylidene)-4-piperidone [<xref ref-type="bibr" rid="B13-molbank-2015-M852">13</xref>]. In this work, we prepared and characterized <italic>N-</italic>benzyl-(3<italic>E</italic>,5<italic>E</italic>)-3,5-bis(2-hydroxybenzylidene)-4-piperidone.</p>
    <sec>
      <title>Experimental Section</title>
      <sec>
        <title>Synthesis of N-Benzyl-(3E,5E)-3,5-bis(2-hydroxybenzylidene)-4-piperidone <italic>(<bold>3</bold>)</italic></title>
        <p>Melting points were determined on an Electrothermal melting point apparatus and are uncorrected. The UV spectra were obtained on a UV Ultraspec 3000 Pro spectrophotometer. The IR spectra were recorded on a Perkin-Elmer 1760X FT-IR (Waltham, MA, USA) in KBr. The mass spectra were recorded with a JEOL JMS-700 (Tokyo, Japan) and a SynaptG2 mass spectrometer (Waters, Milford, MA, USA). <sup>1</sup>H and <sup>13</sup>C-NMR spectra were recorded with an Agilent DD2 system (Santa Clara, CA, USA) operating at 500 (<sup>1</sup>H) and 125 (<sup>13</sup>C) MHz, using residual (&#x3B4;<sub>H</sub> 7.26) and deuterated solvent (&#x3B4;<sub>C</sub> 77.0) peaks of CDCl<sub>3</sub> as reference standards. For synthesis used Mas-II Sineo Microwave. Chromatographic separations were carried out on silica gel 60 (Merck, Darmstadt, Germany). TLC plates were precoated with silica GF<sub>254</sub> (Merck, 0.25 mm) and detection was achieved by spraying with 10% H<sub>2</sub>SO<sub>4</sub> in ethanol, followed by heating.</p>
        <p>The title compound was synthesized by mixing the corresponding <italic>N</italic>-benzyl-4-piperidone (1.89 g, 0.01 mol), 2-hydroxybenzaldehyde (2.44 g, 0.02 mol), 40% aq. NaOH (0.7 mL) and 95% EtOH (5 mL) and was stirred at room temperature for 30 minutes, according to the partially modified procedure of a previous report [<xref ref-type="bibr" rid="B9-molbank-2015-M852">9</xref>], as shown in <xref ref-type="scheme" rid="molbank-2015-M852-sch001">Scheme 1</xref>. The reaction mixture was subjected to microwave irradiation for 3 min at a power of 180 W and temperature of 60 &#xB0;C. The reaction product was cooled and cold water was added. The precipitate formed was filtered and recrystallized from mixture of ethyl acetate&#x2013;methanol to afford <bold>3</bold> (3.58 g, 90%) as an orange crystal, m.p: 143&#x2013;144 &#xB0;C. UV (MeOH) &#x3BB;<sub>max</sub>: 306 nm (&#x3B5; 4,600) and 357 nm (&#x3B5; 5,200). </p>
        <p>IR (KBr) &#x3BD;<sub>max</sub> cm<sup>&#x2212;1</sup>: 3235, 3064, 1706, 1661 and 1604. </p>
        <p><sup>1</sup>H-NMR (Agilent DD2, 500 MHz, CDCl<sub>3</sub>): &#x3B4; (ppm) 8.90 (2H, s), 8.00 (2H, s), 7.40 (2H, d, <italic>J</italic> = 8.0 Hz), 6.90 (2H, d, <italic>J</italic> = 7.5 Hz), 6.80 (2H, d, <italic>J</italic> = 8.0 Hz), 6.70 (2H, d, <italic>J</italic> = 7.5 Hz), 3.83 (2H, s), 3.71 (4H, s). </p>
        <p><sup>13</sup>C-NMR (125 MHz, CDCl<sub>3</sub>): &#x3B4; (ppm) 187.4, 157.6, 139.1, 134.0, 132.0, 131.3, 131.0, 129.8, 129.1, 127.9, 123.4, 120.1, 116.6, 62.1, 55.6. </p>
        <p>HR-ESI-TOFMS: calculated for C<sub>26</sub>H<sub>24</sub>NO<sub>3</sub> <italic>m/z</italic> 398.1756, found [M + H]<sup>+</sup>, <italic>m/z</italic> 398.1750.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2015-M852">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2015-M852-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M852-s001.pdf">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M852-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M852-s002-mod.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M852-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M852-s002.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>This research was partially supported by Directorate General of Higher Education, Ministry of Educatioan and Culture, Indonesia (2012-2013, by YE). </p>
    </ack>
    <notes>
      <title>Author Contributions </title>
      <p>Unang Supratman and Adel Zamri designed the whole experiment and contributed to the manuscript. Yoshihito Shiono measured the NMR and HR-ESI-TOFMS spectra. Yum Eryanti and Tati Herlina synthesize a new curcumin analog and wrote the manuscript. Khalijah Awang and Siti Nadiah Abdul Halim analyzed the NMR and HR-ESI-TOFMS spectra. All authors read and approved the final manuscript.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interst.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2015-M852">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dandia</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>An efficient and highly selective approach for the construction of novel dispiro heterocycles in guanidine-based task-specific [TMG][Ac] ionic liquid</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>5859</fpage>
          <lpage>5863</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2012.08.060</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2015-M852">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rostom</surname>
              <given-names>S.A.F.</given-names>
            </name>
            <name>
              <surname>Hassan</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>El-Subbagh</surname>
              <given-names>H.I.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological evaluation of some polymethoxylated fused pyridine ring system as antitumor agents</article-title>
          <source>Arch. Pharm.</source>
          <year>2009</year>
          <volume>342</volume>
          <fpage>484</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="doi">10.1002/ardp.200900062</pub-id>
          <pub-id pub-id-type="pmid">19714673</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2015-M852">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Iyoki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mohri</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Isobe</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ono</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities</article-title>
          <source>J. Pharm. Bull.</source>
          <year>2005</year>
          <volume>28</volume>
          <fpage>1438</fpage>
          <lpage>1443</lpage>
          <pub-id pub-id-type="doi">10.1248/bpb.28.1438</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2015-M852">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ranjith</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Subbu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Palaniappan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Perumal</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Dharmarajan</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>An atom efficient, solvent-free, green synthesis and antimycobacterial evaluation of 2-amino-6-methyl-4-aryl-8-[(<italic>E</italic>)-arylmethylidene]-5,6,7,8-tetrahydro-4H-pyrano[3,2-<italic>c</italic>]pyridine-3-carbonitriles</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>6459</fpage>
          <lpage>6462</lpage>
        </citation>
      </ref>
      <ref id="B5-molbank-2015-M852">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Babasaheb</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sebastian</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rhonda</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>N.</given-names>
            </name>
             <name>
              <surname>Diederich, Somer-Edgar, Tiffany</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lesley</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>6701</fpage>
          <lpage>6707</lpage>
        </citation>
      </ref>
      <ref id="B6-molbank-2015-M852">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>B.V.</given-names>
            </name>
            <name>
              <surname>Sundari</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Balamurugan</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Menon</surname>
              <given-names>V.P.</given-names>
            </name>
          </person-group>
          <article-title>Prevention of nicotine and streptozotocin treatment induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in diabetic rats</article-title>
          <source>Mol. Cell. Biochem.</source>
          <year>2009</year>
          <volume>331</volume>
          <fpage>127</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="doi">10.1007/s11010-009-0150-1</pub-id>
          <pub-id pub-id-type="pmid">19468831</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2015-M852">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aggarwal</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bharti</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Anticancer potential of curcumin: Preclinical and clinical studies</article-title>
          <source>Anticancer Res.</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>363</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">12680238</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2015-M852">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Becerra</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Microwave-assisted synthesis of pyrimido[4,5-<italic>b</italic>][1,6]naphthyridin-4(3<italic>H</italic>)-ones with potential antitumor activity</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2013</year>
          <volume>60</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2012.11.037</pub-id>
          <pub-id pub-id-type="pmid">23279862</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2015-M852">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2013</year>
          <volume>21</volume>
          <fpage>3959</fpage>
          <lpage>3065</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2013.03.057</pub-id>
          <pub-id pub-id-type="pmid">23611769</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2015-M852">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogs of curcumin in LPS-stimulated RAW 264.7 macrophages</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2010</year>
          <volume>45</volume>
          <fpage>5773</fpage>
          <lpage>5780</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2010.09.037</pub-id>
          <pub-id pub-id-type="pmid">20934787</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2015-M852">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siddiqui</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Simms</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-&#x3B3;</article-title>
          <source>Crit. Care. Med.</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>1874</fpage>
          <lpage>1882</lpage>
          <pub-id pub-id-type="doi">10.1097/01.CCM.0000221921.71300.BF</pub-id>
          <pub-id pub-id-type="pmid">16715036</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2015-M852">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gregory</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dandavati</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tzou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Savagian</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brien</surname>
              <given-names>K. M.</given-names>
            </name>
            <name>
              <surname>Satam</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Patil</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, cytotoxicity, and structure-activity insight of <italic>N</italic>H- and <italic>N</italic>-methyl-3,5-bis(arylidenyl)-4-piperidones</article-title>
          <source>Med. Chem. Res.</source>
          <year>2013</year>
          <volume>22</volume>
          <fpage>5588</fpage>
          <lpage>5597</lpage>
          <pub-id pub-id-type="doi">10.1007/s00044-013-0557-9</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2015-M852">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eryanti</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Herlina</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zamri</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Halim</surname>
              <given-names>S.A.N.</given-names>
            </name>
            <name>
              <surname>Shiono</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Syah</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Awang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Supratman</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>3,5-Bis(2-hydroxybenzylidene)piperidin-4-one</article-title>
          <source>Molbank</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>M825</fpage>
          <pub-id pub-id-type="doi">10.3390/M825</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2015-M852-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2015-M852-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>The synthesis of <italic>N</italic>-benzyl-(3<italic>E</italic>,5<italic>E</italic>)-3,5-bis(2-hydroxybenzylidene)-4-piperidone.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M852-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
